Company Profile

Who:

Stem Cell Sciences (SCS) is an international research and development company specialising in the provision of stem cells and stem cell technologies for research and the clinic.

SCS takes pride in its long-standing relationships with leading academic centres of excellence in the stem cell field, which help maintain the Company’s position at the cutting edge of the stem cell industry.

Stem Cell Sciences has an established track record of commercialisation with international biotechnology and pharmaceutical companies including Pfizer, Sanofi-Aventis, GSK, Chemicon, Deltagen and Lexicon.

What:

Stem Cell Sciences has been active in the stem cell research field since 1994, principally focused on technologies to grow, differentiate, and purify embryonic and neural stem cells. The Company now has a substantial portfolio of patents and patent applications in both adult and embryonic stem cell fields. These include technologies to permit the generation of highly purified stem cells and their differentiated progeny for use in genetic, pharmacological and toxicological screens. Moreover, these technologies can be utilised to provide pure populations of appropriate cell types for transplantation therapies.

Why:

Stem Cell Sciences’ core objective is to develop safe and effective stem cell-based therapies for currently incurable diseases.

Where:

We have business and scientific operations in Edinburgh and Cambridge (UK), Melbourne (Australia) and Kobe (Japan). In 2007 SCS will open new offices in California (USA).  We are incorporated in the United Kingdom, company registration number 5455929.